Clincosm LogoSign in Get a demo

Metastatic Melanoma

Showing NaN - NaN of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
Dec 16, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Magnetic Resonance Imaging using 7 Tesla MRI
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +848 more
Aug 24, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +19 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 19, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +2 more
  • Los Angeles, California
  • +12 more
Jul 27, 2022

Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)

Completed
  • Metastatic Melanoma
  • Placebo for antibiotic
  • +4 more
  • Los Angeles, California
  • +6 more
Jun 7, 2022

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Metastatic Melanoma Trial in Worldwide (Ipilimumab, IMO-2125)

Terminated
  • Metastatic Melanoma
  • Birmingham, Alabama
  • +79 more
Sep 21, 2021

Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))

Completed
Has Results
  • Metastatic Melanoma
  • MORAb-004 (monoclonal antibody)
  • Scottsdale, Arizona
  • +28 more
Aug 6, 2021

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated
Has Results
  • Metastatic Melanoma
  • Head Neck Cancer
  • Birmingham, Alabama
  • +46 more
Jul 12, 2021

Metastatic Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (Aldesleukin)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +3 more
Jun 4, 2021

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Los Angeles, Salt Lake

Terminated
  • Metastatic Melanoma
  • +5 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +4 more
  • Los Angeles, California
  • +1 more
Apr 1, 2021

Metastatic Melanoma Trial in Canada, United States (TH-302)

Terminated
Has Results
  • Metastatic Melanoma
  • Los Angeles, California
  • +6 more
Mar 24, 2021

Metastatic Melanoma Trial in Worldwide (Lifileucel)

Active, not recruiting
  • Metastatic Melanoma
  • Lifileucel
  • La Jolla, California
  • +56 more
Mar 24, 2021

Metastatic Melanoma Trial in United States (NEO-PV-01, Nivolumab, Adjuvant)

Terminated
  • Metastatic Melanoma
  • NEO-PV-01
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Sep 1, 2020

Colon Cancer Metastatic, Head Neck Cancer Metastatic, Metastatic NSCLC Trial in United States (ADXS-NEO)

Unknown status
  • Colon Cancer Metastatic
  • +4 more
  • ADXS-NEO
  • Scottsdale, Arizona
  • +3 more
Aug 10, 2020

Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)

Completed
  • Metastatic Melanoma
  • Los Angeles, California
    University of California Los Angeles (UCLA)
Jul 30, 2020

Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Melanoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +13 more
Nov 14, 2019